title: Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.
abstract: Prion diseases, or transmissible spongiform encephalopathies (TSEs), are fatal neurodegenerative disorders that occur in humans and animals. The neuropathological hallmarks of TSEs are spongiosis, glial proliferation, and neuronal loss. The only known specific molecular marker of TSEs is the abnormal isoform (PrP(Sc)) of the host-encoded prion protein (PrP(C)), which accumulates in the brain of infected subjects and forms infectious prion particles. Although this transmissible agent lacks a specific nucleic acid component, several prion strains have been isolated. Prion strains are characterized by differences in disease outcome, PrP(Sc) distribution patterns, and brain lesion profiles at the terminal stage of the disease. The molecular factors and cellular mechanisms involved in strain-specific neuronal tropism and toxicity remain largely unknown. Currently, no cellular model exists to facilitate in vitro studies of these processes. A few cultured cell lines that maintain persistent scrapie infections have been developed, but only two of them have shown the cytotoxic effects associated with prion propagation. In this study, we have developed primary neuronal cultures to assess in vitro neuronal tropism and toxicity of different prion strains (scrapie strains 139A, ME7, and 22L). We have tested primary neuronal cultures enriched in cerebellar granular, striatal, or cortical neurons. Our results showed that (i) a strain-specific neuronal tropism operated in vitro; (ii) the cytotoxic effect varied among strains and neuronal cell types; (iii) prion propagation and toxicity occurred in two kinetic phases, a replicative phase followed by a toxic phase; and (iv) neurotoxicity peaked when abnormal PrP accumulation reached a plateau.
authors.affiliation: Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Épinière (CRICM), UMRS 975, Equipe Alzheimer's and Prion Diseases, Paris, France.
authors.forename: Samia
authors.initials: S
authors.lastname: Hannaoui
authors.forename: Layal
authors.initials: L
authors.lastname: Maatouk
authors.forename: Nicolas
authors.initials: N
authors.lastname: Privat
authors.forename: Etienne
authors.initials: E
authors.lastname: Levavasseur
authors.forename: Baptiste A
authors.initials: BA
authors.lastname: Faucheux
authors.forename: Stéphane
authors.initials: S
authors.lastname: Haïk
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000473:pathology*; D001921:Brain / Q000378:metabolism / Q000473:pathology; D018929:Cell Culture Techniques; D002478:Cells, Cultured; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000473:pathology*; D018621:PrPC Proteins / Q000378:metabolism; D018620:PrPSc Proteins / Q000378:metabolism; D011328:Prions / Q000502:physiology*; D012608:Scrapie / Q000378:metabolism / Q000473:pathology*
chemical_list: D018621:PrPC Proteins; D018620:PrPSc Proteins; D011328:Prions